Ondansetron
Product Images NDC 53002-0590

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 53002-0590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530020590)

Label Image (Lbl530020590)
Ondansetron 8mg OD tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a package of 10 tablets, with instructions to take the medication as directed by a prescriber. The label includes a barcode, lot number, expiration date, and prescription status (Rx only). Additional instructions and warnings are provided, with space for patient name, clinic name, and prescriber signature.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure of ondansetron, showing its fused ring system including an indole-like structure, a ketone group, and a methyl-substituted imidazole ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.